Holdings
Deerfield Management Company, L.P.
As of Jun 30, 2026, Deerfield Management Company, L.P. reported 63 positions worth US$7.41B. Largest: Nuvalent, Inc., Revolution Medicines, Inc. and Praxis Precision Medicines, Inc. What it bought and sold, with each filing.
| Company | Shares | Value as reported | Change | As of |
|---|---|---|---|---|
| Nuvalent, Inc. | 17.2M | US$2.13B | no change | Jun 30, 2026 |
| Revolution Medicines, Inc. | 2.39M | US$448M | +95,000 | Jun 30, 2026 |
| Praxis Precision Medicines, Inc. | 963K | US$323M | no change | Jun 30, 2026 |
| Viatris Inc. | 20.2M | US$321M | no change | Jun 30, 2026 |
| Centene Corporation | 4.9M | US$315M | −1.02M | Jun 30, 2026 |
| United Therapeutics Corporation | 457K | US$248M | no change | Jun 30, 2026 |
| Cogent Biosciences, Inc. | 5.01M | US$194M | −4.04M | Jun 30, 2026 |
| Genmab A/s | 6.87M | US$189M | +4.4M | Jun 30, 2026 |
| Brookdale Senior Living Inc. | 11.6M | US$187M | no change | Jun 30, 2026 |
| Vera Therapeutics, Inc. | 3.92M | US$168M | +194K | Jun 30, 2026 |